Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PD184352
Description:
PD184352, also known as CI-1040, is a small-molecule inhibitor of MEK enzymes used in studies of MAPK signaling.
Related topic:
Melanoma and MAPK Pathways (13%)
Wikidata ID:
wiki/Q27076005
OpenAlex ID:
keywords/pd184352
Targeting the ERK signaling pathway in cancer therapy
2006
·
Michiaki Kohno
, Jacques Pouyssegur
·
Annals of Medicine
·
475
PDF
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia
2001
·
Michele Milella
, Steven M. Kornblau
, et al.
·
Journal of Clinical Investigation
·
351
PDF
CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
2003
·
L ALLEN
, Judith Sebolt-Leopold
, et al.
·
Seminars in Oncology
·
275
Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway
2001
·
Nimesh Mody
, Jane Leitch
, et al.
·
FEBS Letters
·
271
PDF
Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases
2007
·
Piotr P. Graczyk
·
Journal of Medicinal Chemistry
·
232
Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
2002
·
Chunrong Yu
, Geoffrey Krystal
, et al.
·
PubMed
·
210
Negative Feedback Regulation of FGF Signaling Levels by Pyst1/MKP3 in Chick Embryos
2003
·
Maxwell C. Eblaghie
, J.Simon Lunn
, et al.
·
Current Biology
·
189
PDF
The Chemopreventive Agent Curcumin Is a Potent Radiosensitizer of Human Cervical Tumor Cells via Increased Reactive Oxygen Species Production and Overactivation of the Mitogen-Activated Protein Kinase Pathway
2008
·
Prashanthi Javvadi
, Andrew T. Segan
, et al.
·
Molecular Pharmacology
·
179
Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth
2005
·
D.J. Britton
, I.R. Hutcheson
, et al.
·
Breast Cancer Research and Treatment
·
176
Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
2001
·
Y Dai
, C Yu
, et al.
·
PubMed
·
176
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes
2016
·
Kei-ichi Ozaki
, Midori Awazu
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
173
Extracellular Signal–Regulated Kinase Inhibition Slows Disease Progression in Mice with Polycystic Kidney Disease
2006
·
Sayu Omori
, Mariko Hida
, et al.
·
Journal of the American Society of Nephrology
·
160
Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline‐competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability
2010
·
Hiroshi Kiyonari
, Mari Kaneko
, et al.
·
genesis
·
159
Phosphorylation of STIM1 at ERK1/2 target sites modulates store-operated calcium entry
2010
·
Eulalia Pozo-Guisado
, David G. Campbell
, et al.
·
Journal of Cell Science
·
127
Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
2002
·
Michele Milella
, Zeev Estrov
, et al.
·
Blood
·
123
PDF
Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: Potential proinflammatory mechanisms
2007
·
Melissa J. Thiel
, Caralee J. Schaefer
, et al.
·
Arthritis & Rheumatism
·
114
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1
2002
·
Matthew S. SQUIRES
, Paula M. NIXON
, et al.
·
Biochemical Journal
·
111
PDF
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells
2008
·
Yun Dai
, Shuang Chen
, et al.
·
Blood
·
105
Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44
2003
·
Susumu Tanimura
, Keita Asato
, et al.
·
Biochemical and Biophysical Research Communications
·
101
ERK5 signalling in prostate cancer promotes an invasive phenotype
2011
·
A K Ramsay
, S R C McCracken
, et al.
·
British Journal of Cancer
·
98
PDF
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6–independent mechanism
2002
·
Yun Dai
, Terry H. Landowski
, et al.
·
Blood
·
97
Signal Transduction–Directed Cancer Treatments
2003
·
Edward A. Sausville
, Yusri Elsayed
, et al.
·
The Annual Review of Pharmacology and Toxicology
·
96
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer
2007
·
S R C McCracken
, A Ramsay
, et al.
·
Oncogene
·
95
ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA
2008
·
Shuh-hei Fujishiro
, Susumu Tanimura
, et al.
·
Biochemical and Biophysical Research Communications
·
93
The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways
2009
·
Mohamed Rahmani
, Anh Anderson
, et al.
·
Blood
·
89
Show more works
View as search
Works count:
162
Citation count:
7,271
Year
Topic
Type